|
QuintilesIMS Real-World Insights Bibliography
| A Budget Impact Model of Third-Line or Later Trifluridine/Tipiracil Treatment of Metastatic Colorectal Cancer. |
| Author(s): Ferrufino C, Wiseman F, Wert TD, Barghout V |
| Affiliations(s): QuintilesIMS Health, Falls Church, VA; Taiho Oncology, Priceton, NJ; Taiho Oncology, Inc, Princeton, NJ; VEB Healthcare, Morristown, NJ |
| Publication(s): ASCO |
| Document Type(s): Abstract |
| Countries: USA |
C:
Y: |
Oncology
2017 |
|
L:
A: |
English
Budget impact |
|
 |
| |
| |
| Economic burden of toxicities associated with treating metastatic melanoma in eight countries |
| Author(s): Wehler EA, Zhao Z, Bilir S Pinar, Munakata J, Barber B |
| Affiliations(s): |
| Publication(s): Eur J Health Econ. 2017; 18: 49-58 |
| Document Type(s): Manuscript in preparation |
| Countries: USA |
| Click here for the abstract |
C:
Y: |
Oncology
2017 |
|
L:
A: |
English
Cost analysis |
|
|
| |
| |
| Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective |
| Author(s): Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J6. |
| Affiliations(s): Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it.
2
Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany.
3
Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France.
4
Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany.
5
Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom.
6
AstraZeneca, London, United Kingdom. |
| Publication(s): Breast. 2017 Apr;32:247-255. |
| Document Type(s): Article |
| Countries: France, Germany, Italy, Spain |
| Click here for the abstract |
C:
Y: |
Oncology
2017 |
|
L:
A: |
English
clinical setting: Secondary care, Retrospective database analysis |
|
|
| |
| |
| THE ECONOMIC IMPACT OF DELAYING BRAIN METASTASES IN ALK-POSITIVE NON-SMALL CELL LUNG CANCER IN THE COMMERCIALLY INSURED US POPULATION |
| Author(s): Wong W1, Burudpakdee C2, Seetasith A2, Corvino F3, Yeh D1, Gubens M4 |
| Affiliations(s): 1Genentech, Inc., South San Francisco, CA, USA, 2QuintilesIMS, Fairfax, VA, USA, 3Genesis Research, Hoboken, NJ, USA, 4University of California, San Francisco, San Francisco, CA, USA |
| Publication(s): ISPOR 22nd Annual International Meeting, Boston, 2017 |
| Document Type(s): Abstract |
| Countries: USA |
C:
Y: |
Oncology
2017 |
|
L:
A: |
English
Budget impact, Retrospective database analysis |
|
|
| |
| |
| Real-World Treatment Patterns, Time to Next Treatment, and Economic Outcomes in Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide or Carfilzomib. |
| Author(s): Chen CC1, Parikh K2, Abouzaid S2, Purnomo L2, McGuiness C1B, Hussein M2, Wade RL1 |
| Affiliations(s): 1QuintilesIMS, Plymouth Meeting, Pennsylvania.
2Celgene, Summit, New Jersey |
| Publication(s): J Manag Care Spec Pharm. 2017 Feb;23(2):236-246 |
| Document Type(s): Article |
| Countries: USA |
| Click here for the abstract |
C:
Y: |
Oncology
2017 |
|
L:
A: |
English
Budget impact, Retrospective database analysis |
|
|
| |
| |
| UTILIZATION OF RADIUM-223 DICHLORIDE (RA-223) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN CANADA: A REAL-WORLD RETROSPECTIVE STUDY |
| Author(s): Lapierre M, Fraelic A |
| Affiliations(s): IMS Health, Kirkland, QC, Canada, IMS Health, Canada, Kanata, QC, Canada |
Publication(s): ISPOR 21st, May 21-25 - 2016 Washington DC USA
Value in Health, 2016, 19(3): A162 |
| Document Type(s): Poster |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| REAL-WORLD COMPARISON OF METASTATIC MELANOMA TREATMENTS BETWEEN ACADEMIC AND COMMUNITY HOSPITALS IN CANADA: A RETROSPECTIVE STUDY |
| Author(s): Lapierre M |
| Affiliations(s): IMS Health, Kirkland, QC, Canada |
| Publication(s): ISPOR 21st, May 21-25 - 2016 Washingtown DC USA |
| Document Type(s): Poster |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| TREATMENT PATTERNS OF METASTATIC MELANOMA IN FIVE EUROPEAN COUNTRIES |
| Author(s): Burudpakdee C1, Zhao Z2, Seetasith A1, Ma Q2, Campos Tapias I3, Barber BL2 |
| Affiliations(s): 1 MS Health, Fairfax, VA, USA, 2 Amgen Inc, Thousand Oaks, CA, USA, 3 Amgen SA, Barcelona, Spain |
| Publication(s): ISPOR 21st, May 2016 Washington, USA |
| Document Type(s): Poster |
| Countries: France, Germany, Italy, Spain, UK |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. |
| Author(s): Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. |
| Affiliations(s): 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
2Centre for Observational Research, Amgen Ltd, Uxbridge, UK.
3IMS Health Sweden, Stockholm, Sweden.
|
| Publication(s): Clinical Epidemiology |
| Document Type(s): Article |
| Countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Literature Review |
|
|
| |
| |
| Population-based study of giant cell tumor of bone in Sweden (1983-2011). |
| Author(s): Amelio JM1, Rockberg J2, Hernandez RK3, Sobocki P4, Stryker S5, Bach BA3, Engellau J6, Liede A5 |
| Affiliations(s): 1Amgen Ltd. Uxbridge, UK. Electronic address: justyna.amelio@amgen.com.
2Pygargus/IMS Health, Stockholm, Sweden.
3Amgen Inc. Thousand Oaks, CA, USA.
4Pygargus/IMS Health, Stockholm, Sweden; Karolinska Institutet, Stockholm, Sweden.
5Amgen Inc. South San Francisco, CA, USA.
6Lund University, Lund, Sweden. |
| Publication(s): Cancer Epidemiol |
| Document Type(s): Article |
| Countries: Sweden |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
 1 of 42 
|
|
